resiquimod has been researched along with Leukemia, Myeloid, Acute in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alimoghaddam, K; Hadjati, J; Masoumi, F; Memarian, A; Moazzeni, SM; Nourizadeh, M; Yaghmaie, M | 1 |
| Agarwal, MK; Chakrabarti, A; Gupta, K; Ignatz-Hoover, JJ; Moreton, SA; Sun, K; Wald, DN; Wang, H | 1 |
| Ball, ED; Lane, TA; Li, H; Messer, K; Zhong, R; Zhou, J | 1 |
| Berneman, ZN; Cools, N; Lion, E; Ponsaerts, P; Smits, EL; Van Camp, K; Van Tendeloo, VF | 1 |
| Bontkes, HJ; de Gruijl, TD; Ossenkoppele, GJ; Ruben, JM; van de Loosdrecht, AA; van den Ancker, W; van Luijn, MM; Westers, TM | 1 |
| Alimoghaddam, K; Hadjati, J; Masoumi, F; Memarian, A; Moazzeni, SM; Nourizadeh, M | 1 |
6 other study(ies) available for resiquimod and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
In vitro induction of potent tumor-specific cytotoxic T lymphocytes using TLR agonist-activated AML-DC.
Topics: Adolescent; Adult; Aged; Cell Differentiation; Dendritic Cells; Drug Synergism; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Imidazoles; Immunophenotyping; Immunotherapy, Adoptive; Interleukin-4; Leukemia, Myeloid, Acute; Lipopolysaccharides; Male; Middle Aged; Poly I-C; Recombinant Proteins; T-Lymphocytes, Cytotoxic; Toll-Like Receptors; Young Adult | 2014 |
The role of TLR8 signaling in acute myeloid leukemia differentiation.
Topics: Animals; Antineoplastic Agents; Bone Marrow Cells; Cell Differentiation; Female; Gene Expression Regulation, Leukemic; HL-60 Cells; Humans; Imidazoles; Leukemia, Myeloid, Acute; Membrane Glycoproteins; Mice; Mice, Inbred NOD; Mice, SCID; Myeloid Differentiation Factor 88; p38 Mitogen-Activated Protein Kinases; Signal Transduction; Toll-Like Receptor 7; Toll-Like Receptor 8; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2015 |
Augmentation of autologous T cell reactivity with acute myeloid leukemia (AML) blasts by Toll-like receptor (TLR) agonists.
Topics: Antineoplastic Combined Chemotherapy Protocols; Dendritic Cells; Humans; Imidazoles; Interferon-gamma; Leukemia, Myeloid, Acute; Lipopolysaccharides; T-Lymphocytes, Cytotoxic; Toll-Like Receptors; Tumor Cells, Cultured | 2015 |
The Toll-like receptor 7/8 agonist resiquimod greatly increases the immunostimulatory capacity of human acute myeloid leukemia cells.
Topics: Adjuvants, Immunologic; Adult; Aged; Cell Survival; Coculture Techniques; Cytokines; Female; Histocompatibility Antigens; Humans; Imidazoles; Leukemia, Myeloid, Acute; Leukocytes, Mononuclear; Male; Middle Aged; Natural Killer T-Cells; Toll-Like Receptor 7; Toll-Like Receptor 8; Tumor Cells, Cultured; Young Adult | 2010 |
Targeting Toll-like receptor 7/8 enhances uptake of apoptotic leukemic cells by monocyte-derived dendritic cells but interferes with subsequent cytokine-induced maturation.
Topics: Antigen Presentation; Antigens, Differentiation, B-Lymphocyte; Antigens, Neoplasm; Cancer Vaccines; Cell Movement; Cells, Cultured; Cytokines; Dendritic Cells; Endocytosis; Histocompatibility Antigens Class II; Humans; Imidazoles; Immunotherapy; Leukemia, Myeloid, Acute; Lymphocyte Activation; Monocytes; Peptide Fragments; Toll-Like Receptor 7; Toll-Like Receptor 8 | 2011 |
Synergistic effect of Toll-like receptor 4 and 7/8 agonists is necessary to generate potent blast-derived dendritic cells in Acute Myeloid Leukemia.
Topics: Adolescent; Adult; Aged; Blast Crisis; Cell Differentiation; Cells, Cultured; Dendritic Cells; Drug Synergism; Female; Humans; Imidazoles; Leukemia, Myeloid, Acute; Lipopolysaccharides; Lymphocyte Activation; Male; Middle Aged; Poly I-C; Toll-Like Receptor 4; Toll-Like Receptor 7; Toll-Like Receptor 8; Young Adult | 2012 |